These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001 [TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone therapy and breast cancer. Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723 [TBL] [Abstract][Full Text] [Related]
11. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Kuller LH J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556 [No Abstract] [Full Text] [Related]
12. The breast and the menopause. Wren BG Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):433-47. PubMed ID: 8931904 [No Abstract] [Full Text] [Related]
13. Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis. Asi N; Mohammed K; Haydour Q; Gionfriddo MR; Vargas OL; Prokop LJ; Faubion SS; Murad MH Syst Rev; 2016 Jul; 5(1):121. PubMed ID: 27456847 [TBL] [Abstract][Full Text] [Related]
14. Risk of breast cancer among users of estrogen plus progestogen and unopposed estrogen: is the likelihood of bias symmetrical? Shapiro S Climacteric; 2015 Jun; 18(3):333-5. PubMed ID: 25651904 [No Abstract] [Full Text] [Related]
15. Oestrogens and progestins and breast cancer risk in post-menopausal women. La Vecchia C Pharmacol Res; 1995 Dec; 32(6):323-4. PubMed ID: 8736479 [No Abstract] [Full Text] [Related]
16. The case for postmenopausal hormone therapy. Speroff L Hosp Pract (1995); 1996 Feb; 31(2):75-89. PubMed ID: 8592021 [TBL] [Abstract][Full Text] [Related]
17. Does post-menopausal hormone-replacement therapy increase risk for breast cancer? A perspective on the findings of the Nurses' Health Study. Herd JA; Gotto AM Pharmacol Res; 1995 Dec; 32(6):331-3. PubMed ID: 8736483 [No Abstract] [Full Text] [Related]
18. Do risks of hormone therapy persist after discontinuation? J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802 [No Abstract] [Full Text] [Related]
19. Study outlines further risks associated with hormone replacement therapy. Rollins G Rep Med Guidel Outcomes Res; 2003 Sep; 14(17):1-2, 5. PubMed ID: 13677336 [No Abstract] [Full Text] [Related]
20. The effect of estrogen plus progestin hormone therapy on breast cancer mortality: still unresolved. Schairer C; Brinton LA J Natl Cancer Inst; 2013 Apr; 105(8):513-4. PubMed ID: 23543780 [No Abstract] [Full Text] [Related] [Next] [New Search]